GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2
WEB3 days ago · GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
WEB3 days ago · The Food and Drug Administration asked in 2020 that all Zantac products, which relied on a heartburn drug developed by GSK, be taken off the market. The current Zantac 360 uses a different active ...
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 bln
WEB3 days ago · Oct 9 (Reuters) - GSK (GSK.L) has agreed to pay up to $2.2 billion to settle most pending U.S. state court lawsuits claiming that a discontinued version of the heartburn drug Zantac caused cancer ...
GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement …
WEB3 days ago · On Wednesday, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% ...
GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
WEB3 days ago · GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court cases alleging that its old reflux medication Zantac was contaminated with ...
Zantac maker GSK agrees to pay $2.3 bn in US settlements
WEB3 days ago · British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.
GSK settles vast majority of Zantac claims for $2.2 billion
WEB3 days ago · Photo: Drew Angerer/Getty Images. GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The ...
UK firm GSK to pay $2.2bn over Zantac cancer claims - BBC
WEB3 days ago · UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.
Statement: Zantac (ranitidine) litigation – settlement ... - GSK
WEB3 days ago · 09 October 2024. Issued: London, UK. For media and investors only. Statement: Zantac (ranitidine) litigation – settlement agreements reached. Download (PDF, 130.6KB) GSK to resolve 93% (approximately 80,000 cases) of U.S. state court Zantac product liability cases for up to $2.2 billion. Separate settlement of …
GSK reaches $2.2bn heartburn medication Zantac settlement in US
WEB3 days ago · GSK has reached a $2.2bn settlement to resolve the vast majority of cases linked to its heartburn medicine Zantac, in a move that will help assuage legal concerns overhanging the UK drugmaker.
- Some results have been removed